EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW)

CUSIP: G3141W122

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / *W EXP 10/23/202
Total 13F shares
536,516
Share change
-109,668
Total reported value
$1,229,000
Price per share
$0.76
Number of holders
6
Value change
-$76,912
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G3141W122?
CUSIP G3141W122 identifies EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) as of Q4 2021

As of 31 Dec 2021, EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 536,516 shares. The largest 6 holders included BlackRock Inc., Granite Point Capital Management, L.P., EcoR1 Capital, LLC, Radcliffe Capital Management, L.P., Sagefield Capital LP, and MORGAN STANLEY. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.